Company Profile
CEO
Mr. Jacob Steven Leach(President, CEO & Director)
Sector
Healthcare
Industry
Medical Devices
Employees
11.0K
Beta
1.44
Forward P/E
23.7
52W High
$89.98
52W Low
$54.11
Profit Margin
19.3%
Operating Margin
21.4%
Return on Equity
35.6%
Revenue Growth
15.0%
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated con...
Valuation
Market Cap$29.57B
P/E (TTM)32.89
P/S (TTM)6.20
EV/EBITDA22.06
Cash Flow
FCF Yield+6.1%
SBC Adj. FCF Yield+5.5%
SBC Impact9.6%
Margins & Growth
Profit Margin16.7%
Operating Margin21.4%
Revenue YoY15.0%
Earnings YoY89.3%
Balance
Cash$1.12B
Debt$2.90M
Net Cash$1.12B
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--